The FDA Is Dragging Its Feet While Chinese Vapes Flood Our Markets

President Trump made a promise about cracking down on illicit Chinese vapes, and like most of his promises, he meant it. He picked Robert F. Kennedy Jr. to lead HHS precisely because Kennedy isn’t the type to sit behind a desk shuffling papers while contraband floods American streets. The guy literally participated in a bust that confiscated a million Chinese vapes in Illinois. A million. That’s not a rounding error or a symbolic gesture. That’s actual enforcement.

But here’s where things get frustrating. During testimony before the House Appropriations Committee last week, Kennedy pointed out something that should alarm anyone paying attention. Congress handed the FDA $200 million specifically to crack down on illicit vapes and nicotine products. Good money, clear directive. Yet the FDA has tied itself in knots with regulatory complications that prevent enough American vapes from getting approved. You know what happens when legal alternatives don’t exist? Black markets thrive. It’s economics 101, and apparently nobody at the FDA took that class.

Rep. Chuck Fleischmann from Tennessee asked Kennedy directly about how those enforcement funds were being spent. Kennedy’s answer should have been straightforward. We’re spending it on enforcement, which he confirmed they are doing. But then came the kicker about regulatory roadblocks preventing American companies from entering the market legally. The White House has pushed to open things up, create pathways for legitimate American businesses to compete. The FDA has resisted. Why? Bureaucratic inertia, maybe. Risk aversion, probably. Whatever the reason, it’s unacceptable.

A Republican campaign strategist put it plainly in a statement. President Trump and Secretary Kennedy both understand the political benefits of supporting American industry while crushing Chinese infiltration of our markets. They get that parents don’t want their kids accessing dangerous products manufactured in communist countries with zero quality control. The strategist called out Commissioner Makary and the FDA directly, saying it’s time to step up, open regulatory barriers, and crack down on China. Not next quarter. Not after another study. Now.

This isn’t just about vaping or nicotine products, though those matter plenty. It’s about whether our regulatory agencies work for American interests or against them. Free market capitalism means letting American entrepreneurs compete on fair terms. It doesn’t mean strangling domestic innovation with red tape while foreign bad actors exploit the vacuum. Traditional conservative principles support both strong borders and strong markets. You can’t have the latter when bureaucrats slow walk approvals for American companies while Chinese manufacturers pump out contraband.

Sen. Tom Cotton introduced legislation called the Eliminating Nefarious Distribution of Smuggled Chinese Vapes Act. Catchy acronym aside, the ENDS Chinese Vapes Act would increase penalties on companies enabling Communist China to sell dangerous devices in American markets. Cotton gets it. He wrote to Commissioner Makary back in November making the obvious point that legal, regulated, and satisfactory alternatives must exist if you want to curb demand for illicit Chinese products. Supply and demand doesn’t care about your regulatory timeline.

The irony here is thick enough to cut. We have an administration committed to making America healthy again, protecting children, and supporting domestic manufacturing. We have leadership at HHS willing to personally participate in enforcement actions. We have Congress allocating serious money for the effort. And yet the FDA, the very agency responsible for executing this vision, keeps dragging its feet on approving American alternatives. It’s the kind of government dysfunction that drives ordinary people crazy and makes them wonder whose side these agencies are really on.

Kennedy pointed out the regulatory complication directly during his testimony. That’s significant because he’s not making excuses or deflecting blame. He’s identifying the problem clearly so it can be fixed. The pathway forward isn’t complicated. Approve legitimate American vape products that meet safety standards. Enforce aggressively against illegal Chinese imports. Protect kids and consumers while supporting American business. This isn’t radical policy. It’s common sense wrapped in conservative principles about limited government actually doing its core job well.

The Trump administration promised to crack down on illicit Chinese vapes and selected people who would deliver. Secretary Kennedy has proven he’s serious about enforcement. Now Commissioner Makary and the FDA need to match that energy, remove the regulatory barriers choking American companies, and finish what Trump started.